Tech Company Financing Transactions

Relypsa Funding Round

5AM Ventures, New Leaf Venture Partners and Amgen Ventures participated in a $33 million Series A funding round for Relypsa. The round was announced on 10/29/2007.

Transaction Overview

Company Name
Relypsa
Announced On
10/29/2007
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Series A
Investors

5AM Ventures (Lead Investor) (Scott Rocklage)

New Leaf Venture Partners (Lead Investor) (Vijay Lathi)

Amgen Ventures (Jay Hagen)

Delphi Ventures (Deepa Pakianathan)

Mediphase Venture Partners

Presidio Partners

Sprout Group

Proceeds Purpose
The new company is a spin-out of Ilypsa, Inc., a wholly-owned subsidiary of Amgen (Ilypsa was acquired by Amgen in July 2007 for approximately $420 million). Relypsa commences operations with rights to a proprietary drug discovery platform and a pipeline of product candidates including a potassium binder drug candidate for the treatment of hyperkalemia that is anticipated to enter clinical testing in early 2008.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
700 Saginaw Drive
Redwood City, CA 94063
USA
Phone
650.421.9500
Website
www.relypsa.com
Email Address
[email protected]
Overview
Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.
Profile
Relypsa LinkedIn Company Profile
Social Media
Relypsa Company Twitter Account
Company News
Relypsa News
Facebook
Relypsa on Facebook
YouTube
Relypsa on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Orwin
  John Orwin LinkedIn Profile  John Orwin Twitter Account  John Orwin News  John Orwin on Facebook
Chief Financial Officer
Kristine Ball
  Kristine Ball LinkedIn Profile  Kristine Ball Twitter Account  Kristine Ball News  Kristine Ball on Facebook
VP - General Counsel
Ronald Krasnow
  Ronald Krasnow LinkedIn Profile  Ronald Krasnow Twitter Account  Ronald Krasnow News  Ronald Krasnow on Facebook
VP - Human Resources
Mary Corbett
  Mary Corbett LinkedIn Profile  Mary Corbett Twitter Account  Mary Corbett News  Mary Corbett on Facebook
VP - Regulatory Affairs
Claire Lockey
  Claire Lockey LinkedIn Profile  Claire Lockey Twitter Account  Claire Lockey News  Claire Lockey on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/29/2007: INRIX venture capital transaction
Next: 10/29/2007: Worktopia venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.